Viewing Study NCT02785068

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2026-02-22 @ 3:56 PM
Study NCT ID: NCT02785068
Status: WITHDRAWN
Last Update Posted: 2017-01-11
First Post: 2016-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer
Sponsor: Merrimack Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None Cancer View
None EGFR View
None Metastatic Colorectal Cancer View
None Oncology View
None RAS/RAF Wild-Type View
None Nal-IRI View
None EGFR Inhibitor View
None Oligoclonal Antibody View
None Nanoliposome View
None Nanoliposomal Irinotecan View